Mar 6, 2013 by Max MacalusoWill This Obesity Biotech's Latest Scheme Boost Sales?Will VIVUS' new program help or hinder its business?
Mar 5, 2013 by Max MacalusoWill This HIV Triumph Change History?What does this HIV cure mean for public health?
Feb 26, 2013 by Max MacalusoWhat Does Amarin's ANCHOR Mean for Investors?What does this sNDA mean for investors?
Feb 26, 2013 by Max Macaluso3 Key Takeaways From VIVUS' EarningsWhat should investors watch besides sales?
Feb 21, 2013 by Max MacalusoHot Off the Press: VIVUS' Appeal for EU Approval DeniedThe biotech's obesity drug won't be hitting the EU market any time soon.
Feb 21, 2013 by Max MacalusoShould MannKind Investors Bank on a Partnership?Questions about partnerships continue to follow MannKind.
Feb 21, 2013 by Max MacalusoIs the Price Right for Novo Nordisk?Novo Nordisk is set to charge more for Tresiba.
Feb 20, 2013 by Max MacalusoWhat Is Life Technologies Worth?Is speculation of a buy-out really just speculation?
Feb 20, 2013 by Max MacalusoMerck Is Collaborating With ... Samsung?Don't worry; it's not what you think.
Feb 20, 2013 by Max MacalusoVIVUS Earnings Preview: 3 Things to WatchWhat should investors watch for in Q4?
Feb 19, 2013 by Max Macaluso1 Eli Lilly Division That Roared Into 2013The animal health business drives growth, but not many investors know about it.
Feb 18, 2013 by Max MacalusoCan the Human Brain Project Crack the Code for Big Pharma?A university project that could help big pharma -- long-term.
Feb 15, 2013 by Max Macaluso1 Event Eli Lilly Investors Must WatchA look at three of the most important drugs in diabetes.
Feb 14, 2013 by Max Macaluso1 Weak Link at This Big Pharma1 drug that Eli Lilly has already lost exclusivity for.
Feb 13, 2013 by Max MacalusoWhy Shares of AVEO Hit the Brakes TodayAVEO releases information regarding overall survival.
Feb 13, 2013 by Max MacalusoAnother Breakthrough for This PharmaGood news from the FDA for Pharmacyclics.
Feb 12, 2013 by Max MacalusoCan This Blockbuster Drug Continue to Grow?Who are the key players in the erectile dysfunction space?
